What is Cyclacel Pharmaceuticals Inc (CYCCP) stock price today?

Cyclacel Pharmaceuticals Inc (CYCCP) currently trades at $5.05 per share. The stock has a market capitalization of $9.60M and a P/E ratio of —x.

Is CYCCP stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Cyclacel Pharmaceuticals Inc has a Smart Value Score of 13/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Cyclacel Pharmaceuticals Inc's revenue and earnings?

Cyclacel Pharmaceuticals Inc has trailing twelve-month (TTM) revenue of $10000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-2.05.

CYCC

Cyclacel Pharmaceuticals Inc

NASDAQ: CYCCP · HEALTHCARE · BIOTECHNOLOGY

$5.05

+0.00% today

Updated 2026-04-30

Market cap

$9.60M

P/E ratio

—

P/S ratio

960.24x

EPS (TTM)

$-2.05

Dividend yield

—

52W range

$3 – $9

Volume

—

Market cap

$9.60M

P/E ratio

—

P/S ratio

960.24x

EPS (TTM)

$-2.05

Dividend yield

—

52W range

$3 – $9

Volume

—

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-434000.00

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$373000.00	$420000.00	$43000.00	$10000.00
Net income	$-18.46M	$-21.20M	$-22.55M	$-11.21M	$-988000.00
EPS	—	—	—	—	$-2.05
Free cash flow	$-18.57M	$-20.83M	$-16.12M	$-7.99M	$-434000.00
Profit margin	—	-5,683.11%	-5,370.24%	-26,074.42%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CYCCP	$9.60M	13	3.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Cyclacel Pharmaceuticals Inc trades at $5.05. Our Smart Value Score of 13/100 indicates the stock is weak. TTM revenue stands at $10000.00.

Frequently asked questions

What is Cyclacel Pharmaceuticals Inc's stock price?

Cyclacel Pharmaceuticals Inc (CYCCP) trades at $5.05.

Is Cyclacel Pharmaceuticals Inc overvalued?

Smart Value Score 13/100 (Grade F, Strong Sell).

What is the price target of Cyclacel Pharmaceuticals Inc (CYCCP)?

The analyst target price is $—, representing NaN% downside from the current price of $5.05.

What is Cyclacel Pharmaceuticals Inc's revenue?

TTM revenue is $10000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio960.24x

ROE-276.80%

Beta0.16

50D MA$5.09

200D MA$5.67

Shares out0.01B

Float0.00B

Short ratio—

Avg volume—

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CYCCP vs LLY →CYCCP vs JNJ →CYCCP vs ABBV →Stock screener →